This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Aimee J Spenceley: Innovator in Pharmaceutical Compositions
Introduction
Aimee J Spenceley is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug efficacy.
Latest Patents
Aimee holds a patent for "Pralsetinib pharmaceutical compositions." This patent describes a pharmaceutical composition that includes an amorphous solid dispersion comprising pralsetinib or a pharmaceutically acceptable salt thereof, along with a hydrophilic polymer and an effervescent couple. The invention also covers crystalline forms of pralsetinib and pralsetinib hydrochloride salt, which serve as selective inhibitors for RET. These compositions are designed for the treatment of various disorders, showcasing Aimee's commitment to advancing medical science.
Career Highlights
Aimee is currently associated with Rigel Pharmaceuticals, Incorporated, where she continues to innovate in the pharmaceutical sector. Her work focuses on developing effective treatments that can significantly impact patient care.
Collaborations
Aimee collaborates with talented professionals in her field, including Debra L Mazaik and Kimberly Jean Miller. These partnerships enhance her research and development efforts, leading to groundbreaking advancements in pharmaceuticals.
Conclusion
Aimee J Spenceley is a pioneering inventor whose work in pharmaceutical compositions is making a difference in the medical field. Her innovative approach and dedication to research exemplify the spirit of invention that drives progress in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
